Genovis enters licensing and supply agreement with new bioprocess customer
Genovis has signed a long-term licensing and supply agreement with a US based biotech company for the supply of SmartEnzymes[TM] to be used in the manufacturing of a clinical therapeutic agent. The new customer represents Genovis’ second partner in the Bioprocess application area.The new partner will initially use the Genovis enzyme for the preclinical process development and up-scaling of the manufacturing process to support regulatory submission to enable further clinical development. The initial preclinical development activities are expected to be performed during the first 12-months